CHA
TMO icon

Cedar Hill Associates’s Thermo Fisher Scientific TMO Stock Holding History

Cedar Hill Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$5.34M Sell
23,855
-13,538
-36% -$3.18M 2.05% 15
2018
Q3 		$9.13M Sell
37,393
-3,788
-9% -$871K 2.05% 14
2018
Q2 		$8.53M Sell
41,181
-5,735
-12% -$1.22M 1.77% 17
2018
Q1 		$9.69M Sell
46,916
-9,164
-16% -$1.92M 1.92% 14
2017
Q4 		$10.6M Sell
56,080
-4,304
-7% -$825K 1.85% 19
2017
Q3 		$11.4M Sell
60,384
-4,805
-7% -$870K 1.97% 19
2017
Q2 		$11.4M Sell
65,189
-5,334
-8% -$896K 2.36% 15
2017
Q1 		$10.8M Sell
70,523
-24,650
-26% -$3.77M 2.26% 21
2016
Q4 		$13.4M Sell
95,173
-1,008
-1% -$149K 2.26% 20
2016
Q3 		$15.3M Sell
96,181
-126
-0.1% -$19.4K 2.5% 16
2016
Q2 		$14.2M Sell
96,307
-45,020
-32% -$6.64M 2.44% 19
2016
Q1 		$20M Buy
141,327
+1,640
+1% +$220K 3.48% 2
2015
Q4 		$19.8M Sell
139,687
-1,290
-0.9% -$172K 3.48% 3
2015
Q3 		$17.2M Buy
140,977
+19,548
+16% +$2.55M 3.06% 6
2015
Q2 		$15.8M Buy
121,429
+615
+0.5% +$80.2K 2.48% 7
2015
Q1 		$16.2M Buy
120,814
+1,609
+1% +$207K 2.58% 7
2014
Q4 		$14.9M Buy
119,205
+6,745
+6% +$820K 2.36% 7
2014
Q3 		$13.7M Buy
112,460
+1,838
+2% +$223K 2.21% 9
2014
Q2 		$13.1M Buy
110,622
+7,700
+7% +$906K 2.06% 12
2014
Q1 		$12.4M Sell
102,922
-4,126
-4% -$491K 2.08% 14
2013
Q4 		$11.9M Sell
107,048
-4,324
-4% -$430K 2.12% 13
2013
Q3 		$10.3M Sell
111,372
-6,146
-5% -$556K 1.95% 13
2013
Q2 		$9.95M Buy
+117,518
New +$9.78M 1.95% 14

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cedar Hill Associates's TMO Position: Q4 2018 in Review

Cedar Hill Associates reduced its Thermo Fisher Scientific (TMO) stake by 36% in Q4 2018, selling an estimated $3.18M and leaving 23,855 shares worth $5.34M. The position accounts for 2.05% of the portfolio, ranked #15.

Cedar Hill Associates first reported a position in TMO in Q2 2013 and has held it in 23 quarters since. The position peaked at $20M in Q1 2016. 1,457 funds tracked by Wall St. Rank hold TMO as of Q4 2018.

  • Cedar Hill Associates held 23,855 shares of Thermo Fisher Scientific worth $5.34M as of Q4 2018.
  • Cedar Hill Associates sold 13,538 Thermo Fisher Scientific shares in Q4 2018, an estimated $3.18M.
  • Thermo Fisher Scientific made up 2.05% of Cedar Hill Associates's portfolio in Q4 2018, its #15 holding.
  • Cedar Hill Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 23 quarters since.
  • Cedar Hill Associates's Thermo Fisher Scientific position peaked at $20M in Q1 2016.
  • 1,457 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2018.

Based on Cedar Hill Associates's 13F filing for Q4 2018, filed 13 Feb 2019.